MX9203574A - Metodo biotecnologico para la produccion de peptidos antigenicos relacionados con el antigeno p asociado al melanoma, y para preparar vacunas que los contienen. - Google Patents

Metodo biotecnologico para la produccion de peptidos antigenicos relacionados con el antigeno p asociado al melanoma, y para preparar vacunas que los contienen.

Info

Publication number
MX9203574A
MX9203574A MX9203574A MX9203574A MX9203574A MX 9203574 A MX9203574 A MX 9203574A MX 9203574 A MX9203574 A MX 9203574A MX 9203574 A MX9203574 A MX 9203574A MX 9203574 A MX9203574 A MX 9203574A
Authority
MX
Mexico
Prior art keywords
melanoma
antigen
contain
production
antigenic peptides
Prior art date
Application number
MX9203574A
Other languages
English (en)
Inventor
Joseph P Brown
Gregory D Plowman
Karl E Hellstrom
Anthony F Purchio
Sridhar Pennathur
Charles D Estin
Timothy M Rose
Ingegerd Hellstrom
Shiu-Lok Hu
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26676698&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX9203574(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US07/007,230 external-priority patent/US5262177A/en
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of MX9203574A publication Critical patent/MX9203574A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/0005Vertebrate antigens
    • A61K39/0011Cancer antigens
    • A61K39/00119Melanoma antigens
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407Specifically defined cancers
    • G01N33/5743Specifically defined cancers of skin, e.g. melanoma
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/79Transferrins, e.g. lactoferrins, ovotransferrins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Mycology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • General Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
MX9203574A 1986-02-07 1992-06-26 Metodo biotecnologico para la produccion de peptidos antigenicos relacionados con el antigeno p asociado al melanoma, y para preparar vacunas que los contienen. MX9203574A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US82731386A 1986-02-07 1986-02-07
US07/007,230 US5262177A (en) 1986-02-07 1987-01-27 Recombinant viruses encoding the human melanoma-associated antigen

Publications (1)

Publication Number Publication Date
MX9203574A true MX9203574A (es) 1992-07-01

Family

ID=26676698

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9203574A MX9203574A (es) 1986-02-07 1992-06-26 Metodo biotecnologico para la produccion de peptidos antigenicos relacionados con el antigeno p asociado al melanoma, y para preparar vacunas que los contienen.

Country Status (18)

Country Link
JP (3) JP2664673B2 (es)
BE (1) BE1000175A3 (es)
CH (1) CH675424A5 (es)
DE (1) DE3703702C2 (es)
DK (1) DK63287A (es)
ES (2) ES2012815A6 (es)
FI (1) FI94836C (es)
GR (1) GR870195B (es)
HU (1) HU209144B (es)
IE (1) IE59597B1 (es)
IT (1) IT1222359B (es)
MX (1) MX9203574A (es)
NL (1) NL8700285A (es)
NO (1) NO178931C (es)
NZ (1) NZ219192A (es)
OA (1) OA08478A (es)
PT (1) PT84255B (es)
SE (2) SE506024C2 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19821925A1 (de) * 1998-05-15 1999-11-18 Roehnisch Tim Verfahren zur Herstellung einer Zusammensetzung zur Induktion einer tumorspezifischen Immunantwort, sowie Verwendung der Zusammensetzung zur Behandlung von Neoplasien
JP4414023B2 (ja) * 1999-08-05 2010-02-10 オリエンタル酵母工業株式会社 関節炎関連メラノトランスフェリンの測定方法および試薬
JP4708027B2 (ja) * 2002-10-01 2011-06-22 ノバルティス バクシンズ アンド ダイアグノスティックス,インコーポレーテッド 抗癌組成物および抗感染疾患組成物ならびにこれらを使用する方法
US8207314B2 (en) * 2003-05-16 2012-06-26 Sanofi Pasteur Limited Tumor antigens for prevention and/or treatment of cancer

Also Published As

Publication number Publication date
SE8700466L (sv) 1987-08-08
FI870501A (fi) 1987-08-08
HUT43107A (en) 1987-09-28
NO870475L (no) 1987-08-10
DK63287A (da) 1987-08-08
FI870501A0 (fi) 1987-02-06
SE8700466D0 (sv) 1987-02-06
DE3703702C2 (de) 1997-07-10
NO870475D0 (no) 1987-02-06
SE9202934D0 (sv) 1992-10-07
CH675424A5 (en) 1990-09-28
IE870319L (en) 1987-08-07
FI94836C (fi) 1995-11-10
ES2012815A6 (es) 1990-04-16
ES2017258A6 (es) 1991-01-16
GR870195B (en) 1987-06-10
HU209144B (en) 1994-03-28
JP2664673B2 (ja) 1997-10-15
DE3703702A1 (de) 1988-02-18
NZ219192A (en) 1991-10-25
JPH09135692A (ja) 1997-05-27
FI94836B (fi) 1995-07-31
JPH08280390A (ja) 1996-10-29
OA08478A (fr) 1988-07-29
NO178931C (no) 1996-07-03
NO178931B (no) 1996-03-25
BE1000175A3 (fr) 1988-07-12
IT1222359B (it) 1990-09-05
JPS62294698A (ja) 1987-12-22
IT8719291A0 (it) 1987-02-06
DK63287D0 (da) 1987-02-06
NL8700285A (nl) 1987-09-01
PT84255B (pt) 1989-11-30
SE506024C2 (sv) 1997-11-03
PT84255A (en) 1987-03-01
IE59597B1 (en) 1994-03-09

Similar Documents

Publication Publication Date Title
DK82784D0 (da) Fremgangsmade til fremstilling af lyofiliserede, adsorberede polyvalente vacciner
IT1003824B (it) Metodo per giunzione ed articolo termicamente ripristinabile
ES551113A0 (es) Procedimiento para preparar peptidos trifluormetilcetona-sustituidos.
MX7563E (es) Procedimiento para preparar un complejo inmunogeno que contiene proteinas antigenicas y peptidos
IT8224948A0 (it) Virus vaccinico modificato e metodi per la produzione ed uso del medesimo.
FI894144A0 (fi) Startanordning med en kontinuerlig eller pulsformig ingaong foer test.
ES2109254T3 (es) Proteinas antigenas y vacunas que las contienen para la prevencion de cocidiosis.
DK159555C (da) Opvaskemiddel med thixotrope egenskaber, fremgangsmaade til fremstilling deraf samt anvendelse deraf.
DE3785404D1 (de) Impfstoffe.
ES537459A0 (es) Procedimiento para preparar anticuerpos anti-idiotipicos
ES2023977B3 (es) Procedimiento para la obtencion de helio.
DK164669C (da) 2- eller 3-arylsubstituerede imidazooe1,2-aaapyridiner samt fremgangsmaader til fremstilling deraf
DK163062C (da) Antigen, immunogen, proteinholdig vaccine imod coccidiose
DK337479A (da) Fremgangsmaade til at modificere de antigeniske egenskaber hoset quercitindel-holdigt graespollen-antigen eller fragment deraf
ES2014441B3 (es) Procedimiento y dispositivo para comprobar la estanqueidad de los embalajes.
ES2022258B3 (es) Metodo para preparar esteres de colofonia con estabilidad termica mejorada.
DK159137C (da) Insecticid og acaricid olie-i-vand emulsion, fremgangsmaade til fremstilling deraf og anvendelse af emulsionen
DK196687D0 (da) Kombineret vaccine, samt fremgangsmaade til fremstilling deraf
MX9203574A (es) Metodo biotecnologico para la produccion de peptidos antigenicos relacionados con el antigeno p asociado al melanoma, y para preparar vacunas que los contienen.
ES530383A0 (es) Procedimiento para coadyuvar vacunas exentas de aceite.
DE3751777D1 (de) Impfstoff, der zecken-antigene enthält
DK282384D0 (da) Malariaassocieret antigen, fremgangsmaade til fremstilling deraf og vaccine indeholdende antigenet
IT1051643B (it) Procedimento per la preparazione di fibre proteiche.particolarmente per uso alimentare
IT8021411A0 (it) Polipeptide sintetico attivo come antigene, e procedimento per la sua preparazione.
DE3782960D1 (de) Impfstoffe.

Legal Events

Date Code Title Description
FA Abandonment or withdrawal